News A re-brand for US generics and biosimilars sector Body will campaign to "Keep Medicines in Reach"
News NICE rejects second Alexion ultra-rare disease drug NHS will not fund Kanuma for rare disease LAL-D.
News Norgine rejoins ABPI after eight year absence ABPI says Norgine's support will be important during Brexit.
News Acacia ready to file its anti-vomiting treatment Potential launch in 2018 if FDA approves Baremsis.
News Biotech leaders unite against Trump travel ban Spokesman also causes confusion over pricing policy.
News Isomorphic Labs raises $5bn in massive third round In yet another sign of the appetite for AI companies among investors, Isomorphic Labs has raised a whopping $5bn in a Series C financing.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.